1010 OPTIB – A MULTICENTER PROSPECTIVE OPEN LABEL STUDY ON TENOFOVIR (TDF) FOR CHRONIC HEPATITIS B PATIENTS WITH SUBOPTIMAL RESPONSE TO ADV OR ADV/LAM TREATMENT

Journal of Hepatology ◽

10.1016/s0168-8278(10)61011-2 ◽

2010 ◽

Vol 52 ◽

pp. S390 ◽

Author(s):

M. Levrero ◽

L. Cimino ◽

P. Lampertico ◽

M. Vigano' ◽

G. Gaeta ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Open Label Study ◽

Download Full-text

Safety and efficacy of switching to tenofovir alafenamide (TAF) in virally suppressed chronic hepatitis B (CHB) patients with renal impairment: week 48 results from a phase 2 open label study

Journal of Hepatology ◽

10.1016/s0168-8278(20)32176-0 ◽

2020 ◽

Vol 73 ◽

pp. S868-S869

Author(s):

Harry Janssen ◽

Pietro Lampertico ◽

Chi-Yi Chen ◽

Jeong Heo ◽

Claire Fournier ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Renal Impairment ◽

Chronic Hepatitis B ◽

Phase 2 ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Tenofovir Alafenamide

Download Full-text

43 A multicenter, randomized, open-label study of peginterferon alpha-2b vs interferon alpha-2b for the treatment of chinese patients with HBeAg+VE chronic hepatitis B

Journal of Hepatology ◽

10.1016/s0168-8278(06)80044-9 ◽

2006 ◽

Vol 44 ◽

pp. S20-S21 ◽

Author(s):

H. Zhao ◽

C.-W. Si ◽

L. Wei ◽

M.-B. Wan ◽

Y.-K. Ying ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Interferon Alpha ◽

Chinese Patients ◽

Open Label Study ◽

Label Study ◽

Interferon Alpha 2B

Download Full-text

An open-label study of lamivudine for chronic hepatitis B in six patients with chronic renal failure before and after kidney transplantation

The American Journal of Gastroenterology ◽

10.1111/j.1572-0241.2000.03296.x ◽

2000 ◽

Vol 95 (12) ◽

pp. 3579-3583 ◽

Author(s):

Z. Ben-Ari ◽

E. Broida ◽

Y. Kittai ◽

A. Chagnac ◽

R. Tur-Kaspa

Keyword(s):

Renal Failure ◽

Chronic Hepatitis ◽

Kidney Transplantation ◽

Chronic Renal Failure ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Open Label Study ◽

Label Study ◽

Before And After

Download Full-text

A randomized, open-label study comparing low-dose clevudine plus adefovir combination therapy with clevudine monotherapy in naïve chronic hepatitis B patients

Hepatology International ◽

10.1007/s12072-014-9537-5 ◽

2014 ◽

Vol 8 (3) ◽

pp. 375-381 ◽

Author(s):

Won Young Tak ◽

Jin Mo Yang ◽

Byung Ik Kim ◽

Soon Koo Baik ◽

Gab Jin Cheon ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Combination Therapy ◽

Chronic Hepatitis B ◽

Low Dose ◽

Open Label Study ◽

Download Full-text

Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study

10.1002/hep.24361 ◽

2011 ◽

Vol 54 (1) ◽

pp. 91-100 ◽

Author(s):

Yun-Fan Liaw ◽

Maria Raptopoulou-Gigi ◽

Hugo Cheinquer ◽

Shiv Kumar Sarin ◽

Tawesak Tanwandee ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Efficacy And Safety ◽

Hepatic Decompensation ◽

Open Label Study ◽

Download Full-text

Sa1522 EFFICACY AND SAFETY OF SWITCHING TO TENOFOVIR ALAFENAMIDE IN VIRALLY SUPPRESSED CHRONIC HEPATITIS B PATIENTS WITH RENAL IMPAIRMENT: WEEK 24 RESULTS FROM A PHASE 2 OPEN-LABEL STUDY

Gastroenterology ◽

10.1016/s0016-5085(20)33967-6 ◽

2020 ◽

Vol 158 (6) ◽

pp. S-1319-S-1320

Author(s):

Ho Bae ◽

Huy N. Trinh ◽

Harry L. Janssen ◽

Claire Fournier ◽

Wan-Long Chuang ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Renal Impairment ◽

Chronic Hepatitis B ◽

Phase 2 ◽

Efficacy And Safety ◽

Open Label Study ◽

Label Study ◽

Tenofovir Alafenamide

Download Full-text

Efficacy of thymosin α-1 plus peginterferon α-2a combination therapy compared with peginterferon α-2a monotherapy in HBeAg-positive chronic hepatitis B: A prospective, multicenter, randomized, open-label study

Scandinavian Journal of Gastroenterology ◽

10.3109/00365521.2012.694902 ◽

2012 ◽

Vol 47 (8-9) ◽

pp. 1048-1055 ◽

Author(s):

Bo Hyun Kim ◽

Youn-Jae Lee ◽

Won Kim ◽

Jung-Hwan Yoon ◽

Eun Uk Jung ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Combination Therapy ◽

Chronic Hepatitis B ◽

Open Label Study ◽

Label Study ◽

Positive Chronic Hepatitis ◽

Peginterferon Α

Download Full-text

Safety and efficacy of switching to tenofovir alafenamide (TAF) in virally suppressed chronic hepatitis B (CHB) patients with hepatic impairment: week 48 results from a phase 2 open label study

Journal of Hepatology ◽

10.1016/s0168-8278(20)32187-5 ◽

2020 ◽

Vol 73 ◽

pp. S872

Author(s):

Young-Suk Lim ◽

Chun-yen Lin ◽

Jeong Heo ◽

Ho Bae ◽

Wan-Long Chuang ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Hepatic Impairment ◽

Phase 2 ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Tenofovir Alafenamide

Download Full-text

S1127 Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) in Virally Suppressed Chronic Hepatitis B (CHB) Patients With Renal Impairment: Week 48 Results From a Phase 2 Open-Label Study

The American Journal of Gastroenterology ◽

10.14309/01.ajg.0000778040.44734.f8 ◽

2021 ◽

Vol 116 (1) ◽

pp. S530-S530

Author(s):

Harry Janssen ◽

Jeong Heo ◽

Claire Fournier ◽

Sang Hoon Ahn ◽

Carla S. Coffin ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Renal Impairment ◽

Chronic Hepatitis B ◽

Phase 2 ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Tenofovir Alafenamide

Download Full-text

Sa1525 SAFETY AND EFFICACY OF SWITCHING TO TENOFOVIR ALAFENAMIDE (TAF) IN VIRALLY SUPPRESSED CHRONIC HEPATITIS B (CHB) PATIENTS WITH HEPATIC IMPAIRMENT: WEEK 24 RESULTS FROM A PHASE 2 OPEN-LABEL STUDY

Gastroenterology ◽

10.1016/s0016-5085(20)33970-6 ◽

2020 ◽

Vol 158 (6) ◽

pp. S-1320-S-1321

Author(s):

Carla Coffin ◽

Young-Suk Lim ◽

Ho Bae ◽

Jeong Heo ◽

Aric J Hui ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Hepatic Impairment ◽

Phase 2 ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Tenofovir Alafenamide

Download Full-text